1. Home
  2. EHTH vs MIRA Comparison

EHTH vs MIRA Comparison

Compare EHTH & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

HOLD

Current Price

$1.32

Market Cap

46.0M

Sector

Finance

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$0.84

Market Cap

37.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
MIRA
Founded
1997
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.0M
37.1M
IPO Year
2006
2023

Fundamental Metrics

Financial Performance
Metric
EHTH
MIRA
Price
$1.32
$0.84
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$3.33
N/A
AVG Volume (30 Days)
280.0K
50.2K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
N/A
EPS
N/A
N/A
Revenue
$251,395,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.20
$0.83
52 Week High
$5.89
$2.45

Technical Indicators

Market Signals
Indicator
EHTH
MIRA
Relative Strength Index (RSI) 35.36 35.76
Support Level $1.21 N/A
Resistance Level $1.58 $1.02
Average True Range (ATR) 0.07 0.06
MACD -0.02 -0.01
Stochastic Oscillator 1.30 9.48

Price Performance

Historical Comparison
EHTH
MIRA

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: